Replay available

SKINBIOTHERAPEUTICS PLC (SBTX) — Full Year Results

Full Year Results hosted by SKINBIOTHERAPEUTICS PLC (LSE: SBTX) on Investor Meet Company, held 2024-12-10.

Tue, December 10, 2024 at 5:00 AMendedReplay
SKINBIOTHERAPEUTICS PLC (SBTX) — Full Year Results

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Stuart J Ashman

CEO at SKINBIOTHERAPEUTICS PLC

Manprit Randhawa

CFO at SKINBIOTHERAPEUTICS PLC

Replay transcript excerpt

Good morning, and welcome to the SKINBIOTHERAPEUTICS PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and could be submitted at any time via the q and a tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll, and I'd now like to hand you over to Stuart Ashman, CEO. Good morning, sir. Good morning. Thank you, Amy. Thank you all for your time this morning. This is our our second investor meets in in in in in less than a couple of weeks. So, yeah, we're we're breaking the mold a little bit here. This is our presentation where we will go through the full year results that ended 06/30/2024. We'll obviously talk and reference to some of the things that happened post year end, and we'll try to get this done in an orderly manner. I have seen a number of questions submitted, we will do, as always, our utmost to get through as many of those as as humanly possible. So on the agenda today, we have operational financial highlights. We'll go through the strategy for for the past year and the coming year. We'll do an operational review of our organic businesses, the the pillars that we've talked about on multiple occasions before, and the new inorganic business, the acquisition of Dermatronics and Posture Biotech Solutions. Manpreet will then walk you through a detailed financial review, and then we'll look at a little bit of what's going to happen in the current financial year right throug...

More from Skinbiotherapeutics Plc